PMV Pharmaceuticals Inc
PMVP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$69.86M
Close$
$0.71
48.4% downside
Current Fair Value
48.4% downsideOvervalued by 48.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $69.86 Million |
|---|---|
| Enterprise Value | $57.61 Million |
| Earnings per Share | $-1.48 |
| Beta | 1.35 |
| Outstanding Shares | 53,386,909 |
Return
| Return on Equity | -105.20% |
|---|---|
| Return on Assets | -91.66% |
| Return on Invested Capital | -109.39% |
Valuation & Multiples
| P/E Ratio | -0.92 |
|---|---|
| PEG | 6.26 |
| Price to Sales | - |
| Price to Book Ratio | 1.37 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.74 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.39
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.34
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 64.21% |
|---|---|
| Total Invested | $626▼ 100.00% |
| Investors Holding | 1▼ 64.00% |
About PMV Pharmaceuticals Inc
44 employees
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology...